一家来自美国、以遗传学驱动药物发现为核心的生物科技公司，正布局一个商业潜力已获108亿美元交易印证的抗体疗法领域，并寻求免疫治疗方向的合作与并购机会。

A U.S. biotech company pioneering genetics-driven drug discovery is pursuing opportunities in an antibody-therapy field whose commercial potential was underscored by a US$10.8 billion transaction. The company is seeking partnership and M&A opportunities in immunotherapy.

一家新加坡企业正在打造“轨道AI云”，将算力部署至近地轨道，旨在降低其对地面电力基础设施与地缘政治环境的依赖。公司现正寻求政府机构和企业客户，共同验证这一下一代基础设施模式。

A Singapore-based company is developing an orbital AI cloud, deploying compute capacity in low Earth orbit to reduce reliance on terrestrial power infrastructure and exposure to geopolitical constraints. It is seeking government agencies and enterprise partners to jointly validate this next-generation infrastructure model.

一家新加坡AI公司正自主研发覆盖文本、图像和视频的多模态基础大模型，为智能体应用提供底层能力。公司现正寻找中国—东盟市场的战略投资者与商业化合作伙伴。

A Singapore AI company is developing proprietary multimodal foundation models spanning text, image and video, providing core capabilities for AI-agent applications. It is seeking strategic investors and commercialization partners across the China–ASEAN market.

一家英国深科技公司正将石墨烯技术从实验室推向工业化应用，覆盖碳纤维、储能、半导体等领域。公司以新加坡为区域支点进入中国和东南亚市场，现正寻找战略投资者、产业合作方及具备量产能力的制造伙伴。

A UK deep-tech company is translating graphene innovation from the laboratory into industrial-scale applications across carbon fibre, energy storage and semiconductors. Using Singapore as a regional gateway to China and Southeast Asia, it is seeking strategic investors, industry partners and manufacturing partners with volume-production capabilities.

一家拥有近十年运营经验的领先电竞赛事运营商，正从东南亚拓展至中东、北美和欧洲市场，并寻找能够在赛事、内容与商业化方面开展跨区域合作的伙伴。

A leading esports events operator with a track record spanning nearly a decade is expanding from Southeast Asia into the Middle East, North America and Europe. It is seeking cross-market partners for collaboration in events, content and commercial development.